<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25883404</article-id><article-id pub-id-type="pmc">4339960</article-id><article-id pub-id-type="publisher-id">BLT.14.138420</article-id><article-id pub-id-type="doi">10.2471/BLT.14.138420</article-id><article-categories><subj-group subj-group-type="heading"><subject>Policy &#x00026; Practice</subject></subj-group></article-categories><title-group><article-title>A call for global governance of biobanks</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Un appel &#x000e0; la gouvernance mondiale des biobanques</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">Un llamamiento a la gobernanza mundial de los biobancos</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x00646;&#x0062f;&#x00627;&#x00621; &#x00644;&#x0062a;&#x00635;&#x00631;&#x0064a;&#x00641; &#x00634;&#x00624;&#x00648;&#x00646; &#x00627;&#x00644;&#x00628;&#x00646;&#x00648;&#x00643; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00629; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00635;&#x00639;&#x0064a;&#x0062f; &#x00627;&#x00644;&#x00639;&#x00627;&#x00644;&#x00645;&#x0064a; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x0547c;&#x05401;&#x05168;&#x07403;&#x0751f;&#x07269;&#x06837;&#x0672c;&#x05e93;&#x06cbb;&#x07406;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x0041f;&#x00440;&#x00438;&#x00437;&#x0044b;&#x00432; &#x0043a; &#x00433;&#x0043b;&#x0043e;&#x00431;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x0043c;&#x00443; &#x00443;&#x0043f;&#x00440;&#x00430;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00431;&#x00438;&#x0043e;&#x00431;&#x00430;&#x0043d;&#x0043a;&#x00430;&#x0043c;&#x00438;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Haidan Chen &#x00026; Tikki Pang</alt-title><alt-title alt-title-type="title-running-head">Global biobank governance</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Haidan</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Pang</surname><given-names>Tikki</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><aff id="aff1"><label>a</label>College of Humanities and Development Studies, China Agricultural University, Beijing, <country>China</country>.</aff><aff id="aff2"><label>b</label>Lee Kuan Yew School of Public Policy, National University of Singapore, 469 C Bukit Timah Road, Singapore 259772, <country>Singapore</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Tikki Pang (email: <email xlink:href="spptep@nus.edu.sg">spptep@nus.edu.sg</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>2</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2014</year></pub-date><volume>93</volume><issue>2</issue><fpage>113</fpage><lpage>117</lpage><history><date date-type="received"><day>09</day><month>3</month><year>2014</year></date><date date-type="rev-recd"><day>13</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>02</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>(c) 2015 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><p>The progress in genomic research has led to increased sampling and storage of biological samples in biobanks. Most biobanks are located in high-income countries, but the landscape is rapidly changing as low- and middle-income countries develop their own. When establishing a biobank in any setting, researchers have to consider a series of ethical, legal and social issues beyond those in traditional medical research. In addition, many countries may have inadequate legislative structures and governance frameworks to protect research participants and communities from unfair distribution of risks and benefits. International collaborations are frequently being created to support the establishment and proper running of biobanks in low- and middle-income countries. However, these collaborations cause cross-border issues &#x02013; such as benefit sharing and data access. It is thus necessary to define and implement a fair, equitable and feasible biobank governance framework to ensure a fair balance of risks and benefits among all stakeholders.</p></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9; </title><p>Les progr&#x000e8;s de la recherche g&#x000e9;nomique ont entra&#x000ee;n&#x000e9; une augmentation de l'&#x000e9;chantillonnage et de la conservation des &#x000e9;chantillons biologiques dans les biobanques. La majorit&#x000e9; des biobanques sont situ&#x000e9;es dans les pays &#x000e0; revenu &#x000e9;lev&#x000e9;, mais le paysage &#x000e9;volue rapidement puisque les pays &#x000e0; revenus faible et interm&#x000e9;diaire d&#x000e9;veloppent leurs propres biobanques. Lors de la cr&#x000e9;ation d'une biobanque quel que soit le lieu, les chercheurs doivent prendre en compte un ensemble de questions &#x000e9;thiques, juridiques et sociales qui vont au-del&#x000e0; des questions rencontr&#x000e9;es dans la recherche m&#x000e9;dicale traditionnelle. En outre, de nombreux pays peuvent pr&#x000e9;senter des structures l&#x000e9;gislatives et des cadres de gouvernance insuffisants pour prot&#x000e9;ger les personnes participant &#x000e0; la recherche et les communaut&#x000e9;s de la r&#x000e9;partition in&#x000e9;quitable des risques et des b&#x000e9;n&#x000e9;fices. Les collaborations internationales sont fr&#x000e9;quemment mises en place pour soutenir l&#x02019;&#x000e9;tablissement et le fonctionnement appropri&#x000e9; des biobanques dans les pays &#x000e0; revenus faible et interm&#x000e9;diaire. Cependant, ces collaborations g&#x000e9;n&#x000e8;rent des probl&#x000e8;mes transfrontaliers, tels que le partage des b&#x000e9;n&#x000e9;fices et l'acc&#x000e8;s aux donn&#x000e9;es. Il est donc n&#x000e9;cessaire de d&#x000e9;finir et de mettre en &#x00153;uvre une gouvernance des biobanques &#x000e9;quitable et r&#x000e9;alisable pour assurer un juste &#x000e9;quilibre des risques et des b&#x000e9;n&#x000e9;fices entre tous les acteurs.</p></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><p>Los avances en la investigaci&#x000f3;n gen&#x000f3;mica han dado lugar a una mayor toma y almacenamiento de muestras biol&#x000f3;gicas en biobancos. La mayor&#x000ed;a de los biobancos se encuentran en pa&#x000ed;ses de ingresos altos, pero el panorama est&#x000e1; cambiando r&#x000e1;pidamente a medida que los pa&#x000ed;ses de ingresos bajos y medios desarrollan sus propios biobancos. A la hora de establecer un biobanco en una ubicaci&#x000f3;n cualquiera, los investigadores deben tener en cuenta una serie de cuestiones &#x000e9;ticas, legales y sociales m&#x000e1;s all&#x000e1; de las cuestiones de la investigaci&#x000f3;n m&#x000e9;dica tradicional. Adem&#x000e1;s, es posible que muchos pa&#x000ed;ses no cuenten con estructuras legislativas adecuadas y dispongan de marcos de gobierno para proteger a los participantes de la investigaci&#x000f3;n y a las comunidades frente a la distribuci&#x000f3;n injusta de riesgos y beneficios. Por ello, con frecuencia se crean colaboraciones internacionales para apoyar el establecimiento y funcionamiento adecuados de los biobancos en pa&#x000ed;ses de ingresos bajos y medios. No obstante, estas colaboraciones provocan problemas transfronterizos como el reparto de beneficios y el acceso a los datos. Por tanto, es necesario definir y poner en pr&#x000e1;ctica un marco de gobernanza de los biobancos justo, equitativo y viable para garantizar un equilibrio justo de riesgos y beneficios entre todos los interesados.</p></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><p>&#x00623;&#x0062f;&#x00649; &#x00627;&#x00644;&#x0062a;&#x00642;&#x0062f;&#x00645; &#x00641;&#x0064a; &#x00628;&#x0062d;&#x00648;&#x0062b; &#x00627;&#x00644;&#x0062c;&#x0064a;&#x00646;&#x00648;&#x00645; &#x00625;&#x00644;&#x00649; &#x00627;&#x00644;&#x00632;&#x0064a;&#x00627;&#x0062f;&#x00629; &#x00641;&#x0064a; &#x0062c;&#x00645;&#x00639; &#x00627;&#x00644;&#x00639;&#x0064a;&#x00646;&#x00627;&#x0062a; &#x00648;&#x0062a;&#x0062e;&#x00632;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00639;&#x0064a;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00646;&#x00648;&#x00643; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00629;. &#x00648;&#x0062a;&#x00642;&#x00639; &#x00645;&#x00639;&#x00638;&#x00645; &#x00627;&#x00644;&#x00628;&#x00646;&#x00648;&#x00643; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00631;&#x0062a;&#x00641;&#x00639;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644;&#x0060c; &#x0063a;&#x0064a;&#x00631; &#x00623;&#x00646; &#x00627;&#x00644;&#x00645;&#x00634;&#x00647;&#x0062f; &#x0064a;&#x0062a;&#x0063a;&#x0064a;&#x00631; &#x00628;&#x00634;&#x00643;&#x00644; &#x00633;&#x00631;&#x0064a;&#x00639; &#x00646;&#x00638;&#x00631;&#x00627;&#x0064b; &#x00644;&#x00625;&#x00646;&#x00634;&#x00627;&#x00621; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00646;&#x0062e;&#x00641;&#x00636;&#x00629; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644; &#x00628;&#x00646;&#x00648;&#x00643;&#x00627;&#x0064b; &#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00629; &#x0062e;&#x00627;&#x00635;&#x00629; &#x00628;&#x00647;&#x00627;. &#x00648;&#x00639;&#x00646;&#x0062f; &#x00625;&#x00646;&#x00634;&#x00627;&#x00621; &#x00628;&#x00646;&#x00643; &#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a; &#x00641;&#x0064a; &#x00623;&#x0064a; &#x00645;&#x00646;&#x00637;&#x00642;&#x00629;&#x0060c; &#x0064a;&#x0062a;&#x00639;&#x0064a;&#x00646; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00628;&#x00627;&#x0062d;&#x0062b;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00646;&#x00638;&#x00631; &#x00641;&#x0064a; &#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00633;&#x00627;&#x00626;&#x00644; &#x00627;&#x00644;&#x00623;&#x0062e;&#x00644;&#x00627;&#x00642;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00644;&#x00642;&#x00627;&#x00646;&#x00648;&#x00646;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00644;&#x00627;&#x0062c;&#x0062a;&#x00645;&#x00627;&#x00639;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x0062a;&#x0062c;&#x00627;&#x00648;&#x00632; &#x00627;&#x00644;&#x00645;&#x00633;&#x00627;&#x00626;&#x00644; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x0062a;&#x00636;&#x00645;&#x00646;&#x00647;&#x00627; &#x00627;&#x00644;&#x00628;&#x0062d;&#x00648;&#x0062b; &#x00627;&#x00644;&#x00637;&#x00628;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00642;&#x00644;&#x0064a;&#x0062f;&#x0064a;&#x00629;. &#x00628;&#x00627;&#x00644;&#x00625;&#x00636;&#x00627;&#x00641;&#x00629; &#x00625;&#x00644;&#x00649; &#x00630;&#x00644;&#x00643;&#x0060c; &#x00642;&#x0062f; &#x0062a;&#x00643;&#x00648;&#x00646; &#x00644;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00639;&#x0062f;&#x0064a;&#x0062f; &#x00645;&#x00646; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00647;&#x0064a;&#x00627;&#x00643;&#x00644; &#x0062a;&#x00634;&#x00631;&#x0064a;&#x00639;&#x0064a;&#x00629; &#x00648;&#x00623;&#x00637;&#x00631; &#x00644;&#x0062a;&#x00635;&#x00631;&#x0064a;&#x00641; &#x00627;&#x00644;&#x00634;&#x00624;&#x00648;&#x00646; &#x0063a;&#x0064a;&#x00631; &#x00643;&#x00627;&#x00641;&#x0064a;&#x00629; &#x00644;&#x0062d;&#x00645;&#x00627;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x00634;&#x00627;&#x00631;&#x00643;&#x0064a;&#x00646; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x0062d;&#x00648;&#x0062b; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062c;&#x0062a;&#x00645;&#x00639;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062d;&#x00644;&#x0064a;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x0062a;&#x00648;&#x00632;&#x0064a;&#x00639; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00645;&#x00646;&#x00635;&#x00641; &#x00644;&#x00644;&#x00645;&#x0062e;&#x00627;&#x00637;&#x00631; &#x00648;&#x00627;&#x00644;&#x00641;&#x00648;&#x00627;&#x00626;&#x0062f;. &#x00648;&#x0064a;&#x0062c;&#x00631;&#x00649; &#x00641;&#x0064a; &#x00627;&#x00644;&#x0063a;&#x00627;&#x00644;&#x00628; &#x00625;&#x00646;&#x00634;&#x00627;&#x00621; &#x00623;&#x00648;&#x0062c;&#x00647; &#x00627;&#x00644;&#x0062a;&#x00639;&#x00627;&#x00648;&#x00646; &#x00627;&#x00644;&#x0062f;&#x00648;&#x00644;&#x0064a; &#x00644;&#x0062f;&#x00639;&#x00645; &#x00625;&#x00646;&#x00634;&#x00627;&#x00621; &#x00627;&#x00644;&#x00628;&#x00646;&#x00648;&#x00643; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00629; &#x00648;&#x00625;&#x0062f;&#x00627;&#x00631;&#x0062a;&#x00647;&#x00627; &#x00628;&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; &#x00627;&#x00644;&#x00645;&#x00646;&#x00627;&#x00633;&#x00628;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00646;&#x0062e;&#x00641;&#x00636;&#x00629; &#x00648;&#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00648;&#x00633;&#x00637;&#x00629; &#x00627;&#x00644;&#x0062f;&#x0062e;&#x00644;. &#x00648;&#x00645;&#x00639; &#x00630;&#x00644;&#x00643;&#x0060c; &#x0062a;&#x0062a;&#x00633;&#x00628;&#x00628; &#x00623;&#x00648;&#x0062c;&#x00647; &#x00627;&#x00644;&#x0062a;&#x00639;&#x00627;&#x00648;&#x00646; &#x00647;&#x00630;&#x00647; &#x00641;&#x0064a; &#x00645;&#x00633;&#x00627;&#x00626;&#x00644; &#x00639;&#x00627;&#x00628;&#x00631;&#x00629; &#x00644;&#x00644;&#x0062d;&#x0062f;&#x00648;&#x0062f; <styled-content style-type="direction" style="direction:ltr;">- </styled-content>&#x00645;&#x0062b;&#x00644; &#x00645;&#x00634;&#x00627;&#x00631;&#x00643;&#x00629; &#x00627;&#x00644;&#x00641;&#x00648;&#x00627;&#x00626;&#x0062f; &#x00648;&#x00625;&#x0062a;&#x00627;&#x0062d;&#x00629; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a;. &#x00648;&#x00645;&#x00646; &#x0062b;&#x00645;&#x0060c; &#x00645;&#x00646; &#x00627;&#x00644;&#x00636;&#x00631;&#x00648;&#x00631;&#x0064a; &#x0062a;&#x0062d;&#x0062f;&#x0064a;&#x0062f; &#x00625;&#x00637;&#x00627;&#x00631; &#x00645;&#x00646;&#x00635;&#x00641; &#x00648;&#x00639;&#x00627;&#x0062f;&#x00644; &#x00648;&#x00645;&#x0062c;&#x0062f; &#x00644;&#x0062a;&#x00635;&#x00631;&#x0064a;&#x00641; &#x00634;&#x00624;&#x00648;&#x00646; &#x00627;&#x00644;&#x00628;&#x00646;&#x00648;&#x00643; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00648;&#x00644;&#x00648;&#x0062c;&#x0064a;&#x00629; &#x00628;&#x0063a;&#x0064a;&#x00629; &#x00636;&#x00645;&#x00627;&#x00646; &#x0062a;&#x00648;&#x00627;&#x00632;&#x00646; &#x00645;&#x00646;&#x00635;&#x00641; &#x00644;&#x00644;&#x00645;&#x0062e;&#x00627;&#x00637;&#x00631; &#x00648;&#x00627;&#x00644;&#x00641;&#x00648;&#x00627;&#x00626;&#x0062f; &#x00641;&#x0064a;&#x00645;&#x00627; &#x00628;&#x0064a;&#x00646; &#x0062c;&#x00645;&#x0064a;&#x00639; &#x00623;&#x00635;&#x0062d;&#x00627;&#x00628; &#x00627;&#x00644;&#x00645;&#x00635;&#x00644;&#x0062d;&#x00629;. </p></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><p>&#x057fa;&#x056e0;&#x07ec4;&#x07814;&#x07a76;&#x07684;&#x053d1;&#x05c55;&#x05df2;&#x05bfc;&#x081f4;&#x0751f;&#x07269;&#x06837;&#x0672c;&#x05e93;&#x0751f;&#x07269;&#x06837;&#x054c1;&#x091c7;&#x06837;&#x0548c;&#x05b58;&#x050a8;&#x07684;&#x0589e;&#x052a0;&#x03002;&#x05927;&#x0591a;&#x06570;&#x0751f;&#x07269;&#x06837;&#x0672c;&#x05e93;&#x04f4d;&#x04e8e;&#x09ad8;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x0ff0c;&#x04f46;&#x0662f;&#x056e0;&#x04e3a;&#x04e2d;&#x04f4e;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x04e5f;&#x05728;&#x053d1;&#x05c55;&#x081ea;&#x06709;&#x07684;&#x0751f;&#x07269;&#x06837;&#x0672c;&#x05e93;&#x0ff0c;&#x073b0;&#x05728;&#x060c5;&#x051b5;&#x04e5f;&#x05728;&#x05feb;&#x0901f;&#x053d8;&#x05316;&#x03002;&#x05728;&#x04efb;&#x04f55;&#x06761;&#x04ef6;&#x04e2d;&#x05efa;&#x07acb;&#x0751f;&#x07269;&#x06837;&#x0672c;&#x05e93;&#x065f6;&#x0ff0c;&#x07814;&#x07a76;&#x04eba;&#x05458;&#x090fd;&#x05fc5;&#x0987b;&#x08003;&#x08651;&#x04e00;&#x07cfb;&#x05217;&#x08d85;&#x08d8a;&#x04f20;&#x07edf;&#x0533b;&#x05b66;&#x07814;&#x07a76;&#x07684;&#x04f26;&#x07406;&#x03001;&#x06cd5;&#x05f8b;&#x0548c;&#x0793e;&#x04f1a;&#x095ee;&#x09898;&#x03002;&#x06b64;&#x05916;&#x0ff0c;&#x08bb8;&#x0591a;&#x056fd;&#x05bb6;&#x053ef;&#x080fd;&#x04e0d;&#x05177;&#x06709;&#x05145;&#x05206;&#x07684;&#x07acb;&#x06cd5;&#x07ed3;&#x06784;&#x0548c;&#x06cbb;&#x07406;&#x06846;&#x067b6;&#x06765;&#x04fdd;&#x062a4;&#x07814;&#x07a76;&#x053c2;&#x04e0e;&#x08005;&#x0548c;&#x0793e;&#x0533a;&#x0514d;&#x053d7;&#x098ce;&#x09669;&#x0548c;&#x06536;&#x076ca;&#x07684;&#x04e0d;&#x0516c;&#x05e73;&#x05206;&#x05e03;&#x03002;&#x056fd;&#x09645;&#x05408;&#x04f5c;&#x088ab;&#x09891;&#x09891;&#x053d1;&#x08d77;&#x0ff0c;&#x06765;&#x0652f;&#x06301;&#x04e2d;&#x04f4e;&#x06536;&#x05165;&#x056fd;&#x05bb6;&#x0751f;&#x07269;&#x06837;&#x0672c;&#x05e93;&#x07684;&#x05efa;&#x07acb;&#x0548c;&#x0826f;&#x0597d;&#x08fd0;&#x08425;&#x03002;&#x07136;&#x0800c;&#x0ff0c;&#x08fd9;&#x04e9b;&#x05408;&#x04f5c;&#x05bfc;&#x081f4;&#x08de8;&#x05883;&#x095ee;&#x09898;&#x0ff0c;&#x05982;&#x05229;&#x076ca;&#x05171;&#x04eab;&#x0548c;&#x06570;&#x0636e;&#x08bbf;&#x095ee;&#x03002;&#x056e0;&#x06b64;&#x0ff0c;&#x06709;&#x05fc5;&#x08981;&#x05b9a;&#x04e49;&#x0548c;&#x05b9e;&#x073b0;&#x04e00;&#x04e2a;&#x0516c;&#x05e73;&#x03001;&#x0516c;&#x06b63;&#x0548c;&#x053ef;&#x0884c;&#x07684;&#x0751f;&#x07269;&#x06837;&#x0672c;&#x05e93;&#x06cbb;&#x07406;&#x06846;&#x067b6;&#x0ff0c;&#x04ee5;&#x0786e;&#x04fdd;&#x06240;&#x06709;&#x05229;&#x076ca;&#x076f8;&#x05173;&#x08005;&#x04e4b;&#x095f4;&#x098ce;&#x09669;&#x0548c;&#x06536;&#x076ca;&#x07684;&#x0516c;&#x05e73;&#x05e73;&#x08861;&#x03002;</p></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><p>&#x0041f;&#x00440;&#x0043e;&#x00433;&#x00440;&#x00435;&#x00441;&#x00441; &#x00432; &#x00433;&#x00435;&#x0043d;&#x0043e;&#x0043c;&#x0043d;&#x0044b;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x00445; &#x0043f;&#x00440;&#x00438;&#x00432;&#x00435;&#x0043b; &#x0043a; &#x00443;&#x00432;&#x00435;&#x0043b;&#x00438;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x0043e;&#x00442;&#x00431;&#x0043e;&#x00440;&#x00430; &#x00438; &#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00431;&#x00438;&#x0043e;&#x0043b;&#x0043e;&#x00433;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00445; &#x0043e;&#x00431;&#x00440;&#x00430;&#x00437;&#x00446;&#x0043e;&#x00432; &#x00432; &#x00431;&#x00438;&#x0043e;&#x00431;&#x00430;&#x0043d;&#x0043a;&#x00430;&#x00445;. &#x00411;&#x0043e;&#x0043b;&#x0044c;&#x00448;&#x00438;&#x0043d;&#x00441;&#x00442;&#x00432;&#x0043e; &#x00431;&#x00438;&#x0043e;&#x00431;&#x00430;&#x0043d;&#x0043a;&#x0043e;&#x00432; &#x00440;&#x00430;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0043e;&#x00436;&#x00435;&#x0043d;&#x0043e; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x00432;&#x0044b;&#x00441;&#x0043e;&#x0043a;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x0043e;&#x00432;, &#x0043d;&#x0043e; &#x00441;&#x00438;&#x00442;&#x00443;&#x00430;&#x00446;&#x00438;&#x0044f; &#x00431;&#x0044b;&#x00441;&#x00442;&#x00440;&#x0043e; &#x0043c;&#x00435;&#x0043d;&#x0044f;&#x00435;&#x00442;&#x00441;&#x0044f;, &#x00442;&#x00430;&#x0043a; &#x0043a;&#x00430;&#x0043a; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x0044b; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x00440;&#x00430;&#x00437;&#x00440;&#x00430;&#x00431;&#x00430;&#x00442;&#x0044b;&#x00432;&#x00430;&#x0044e;&#x00442; &#x00441;&#x00432;&#x0043e;&#x00438; &#x00441;&#x0043e;&#x00431;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00431;&#x00438;&#x0043e;&#x00431;&#x00430;&#x0043d;&#x0043a;&#x00438;. &#x0041f;&#x00440;&#x00438; &#x0043e;&#x00440;&#x00433;&#x00430;&#x0043d;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00438; &#x00431;&#x00438;&#x0043e;&#x00431;&#x00430;&#x0043d;&#x0043a;&#x00430; &#x00432; &#x0043b;&#x0044e;&#x00431;&#x0044b;&#x00445; &#x00443;&#x00441;&#x0043b;&#x0043e;&#x00432;&#x00438;&#x0044f;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x00442;&#x00435;&#x0043b;&#x00438; &#x00434;&#x0043e;&#x0043b;&#x00436;&#x0043d;&#x0044b; &#x00440;&#x00430;&#x00441;&#x00441;&#x0043c;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00442;&#x0044c; &#x00440;&#x0044f;&#x00434; &#x0044d;&#x00442;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00445;, &#x0043f;&#x00440;&#x00430;&#x00432;&#x0043e;&#x00432;&#x0044b;&#x00445; &#x00438; &#x00441;&#x0043e;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x00432;&#x0043e;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x0043e;&#x00432;, &#x0043f;&#x0043e;&#x0043c;&#x00438;&#x0043c;&#x0043e; &#x00442;&#x00435;&#x00445;, &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00435; &#x00443;&#x00436;&#x00435; &#x00443;&#x00447;&#x00442;&#x00435;&#x0043d;&#x0044b; &#x00432; &#x00442;&#x00440;&#x00430;&#x00434;&#x00438;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043c;&#x00435;&#x00434;&#x00438;&#x00446;&#x00438;&#x0043d;&#x00441;&#x0043a;&#x00438;&#x00445; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x00445;. &#x0041a;&#x00440;&#x0043e;&#x0043c;&#x00435; &#x00442;&#x0043e;&#x00433;&#x0043e;, &#x0043c;&#x0043d;&#x0043e;&#x00433;&#x00438;&#x00435; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x0044b; &#x0043c;&#x0043e;&#x00433;&#x00443;&#x00442; &#x00438;&#x0043c;&#x00435;&#x00442;&#x0044c; &#x0043d;&#x00435;&#x00441;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00448;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00437;&#x00430;&#x0043a;&#x0043e;&#x0043d;&#x0043e;&#x00434;&#x00430;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00435; &#x00438; &#x00443;&#x0043f;&#x00440;&#x00430;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00435; &#x00441;&#x00442;&#x00440;&#x00443;&#x0043a;&#x00442;&#x00443;&#x00440;&#x0044b; &#x00434;&#x0043b;&#x0044f; &#x00437;&#x00430;&#x00449;&#x00438;&#x00442;&#x0044b; &#x00443;&#x00447;&#x00430;&#x00441;&#x00442;&#x0043d;&#x00438;&#x0043a;&#x0043e;&#x00432; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00438; &#x00441;&#x0043e;&#x0043e;&#x00431;&#x00449;&#x00435;&#x00441;&#x00442;&#x00432; &#x0043e;&#x00442; &#x0043d;&#x00435;&#x00441;&#x0043f;&#x00440;&#x00430;&#x00432;&#x00435;&#x00434;&#x0043b;&#x00438;&#x00432;&#x0043e;&#x00433;&#x0043e; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00440;&#x00438;&#x00441;&#x0043a;&#x0043e;&#x00432; &#x00438; &#x00432;&#x0044b;&#x00433;&#x0043e;&#x00434;. &#x00414;&#x0043b;&#x0044f; &#x0043f;&#x0043e;&#x00434;&#x00434;&#x00435;&#x00440;&#x00436;&#x0043a;&#x00438; &#x00441;&#x00442;&#x00430;&#x0043d;&#x0043e;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00438; &#x0043d;&#x00430;&#x00434;&#x0043b;&#x00435;&#x00436;&#x00430;&#x00449;&#x00435;&#x00439; &#x00440;&#x00430;&#x00431;&#x0043e;&#x00442;&#x0044b; &#x00431;&#x00438;&#x0043e;&#x00431;&#x00430;&#x0043d;&#x0043a;&#x0043e;&#x00432; &#x00432; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00441; &#x0043d;&#x00438;&#x00437;&#x0043a;&#x00438;&#x0043c; &#x00438; &#x00441;&#x00440;&#x00435;&#x00434;&#x0043d;&#x00438;&#x0043c; &#x00443;&#x00440;&#x0043e;&#x00432;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x0043e;&#x00445;&#x0043e;&#x00434;&#x0043e;&#x00432; &#x00447;&#x00430;&#x00441;&#x00442;&#x0043e; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x00443;&#x0044e;&#x00442;&#x00441;&#x0044f; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443;&#x0043d;&#x00430;&#x00440;&#x0043e;&#x00434;&#x0043d;&#x0044b;&#x00435; &#x00441;&#x00445;&#x00435;&#x0043c;&#x0044b; &#x00441;&#x0043e;&#x00442;&#x00440;&#x00443;&#x00434;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x00430;. &#x0041e;&#x00434;&#x0043d;&#x00430;&#x0043a;&#x0043e; &#x0043f;&#x0043e;&#x00434;&#x0043e;&#x00431;&#x0043d;&#x0043e;&#x00435; &#x00441;&#x0043e;&#x00442;&#x00440;&#x00443;&#x00434;&#x0043d;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x0043e; &#x00432;&#x0044b;&#x00437;&#x0044b;&#x00432;&#x00430;&#x00435;&#x00442; &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00442;&#x00440;&#x00430;&#x0043d;&#x00441;&#x00433;&#x00440;&#x00430;&#x0043d;&#x00438;&#x00447;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x00440;&#x0043e;&#x00431;&#x0043b;&#x00435;&#x0043c;&#x0044b;, &#x00442;&#x00430;&#x0043a;&#x00438;&#x00435; &#x0043a;&#x00430;&#x0043a; &#x00441;&#x0043e;&#x00432;&#x0043c;&#x00435;&#x00441;&#x00442;&#x0043d;&#x0043e;&#x00435; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435; &#x00432;&#x0044b;&#x00433;&#x0043e;&#x00434; &#x00438; &#x00434;&#x0043e;&#x00441;&#x00442;&#x00443;&#x0043f; &#x0043a; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x0043c;. &#x00422;&#x00430;&#x0043a;&#x00438;&#x0043c; &#x0043e;&#x00431;&#x00440;&#x00430;&#x00437;&#x0043e;&#x0043c;, &#x0043d;&#x00435;&#x0043e;&#x00431;&#x00445;&#x0043e;&#x00434;&#x00438;&#x0043c;&#x0043e; &#x00440;&#x00430;&#x00437;&#x00440;&#x00430;&#x00431;&#x0043e;&#x00442;&#x00430;&#x00442;&#x0044c; &#x00438; &#x00432;&#x0043d;&#x00435;&#x00434;&#x00440;&#x00438;&#x00442;&#x0044c; &#x00447;&#x00435;&#x00441;&#x00442;&#x0043d;&#x00443;&#x0044e;, &#x00440;&#x00430;&#x00432;&#x0043d;&#x0043e;&#x0043f;&#x00440;&#x00430;&#x00432;&#x0043d;&#x00443;&#x0044e; &#x00438; &#x0043e;&#x00441;&#x00443;&#x00449;&#x00435;&#x00441;&#x00442;&#x00432;&#x00438;&#x0043c;&#x00443;&#x0044e; &#x00441;&#x00442;&#x00440;&#x00443;&#x0043a;&#x00442;&#x00443;&#x00440;&#x00443; &#x00443;&#x0043f;&#x00440;&#x00430;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00431;&#x00438;&#x0043e;&#x00431;&#x00430;&#x0043d;&#x0043a;&#x00430;&#x0043c;&#x00438; &#x00434;&#x0043b;&#x0044f; &#x0043e;&#x00431;&#x00435;&#x00441;&#x0043f;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00441;&#x0043f;&#x00440;&#x00430;&#x00432;&#x00435;&#x00434;&#x0043b;&#x00438;&#x00432;&#x0043e;&#x00433;&#x0043e; &#x00441;&#x00431;&#x00430;&#x0043b;&#x00430;&#x0043d;&#x00441;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00440;&#x00438;&#x00441;&#x0043a;&#x0043e;&#x00432; &#x00438; &#x00432;&#x0044b;&#x00433;&#x0043e;&#x00434; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00432;&#x00441;&#x00435;&#x0043c;&#x00438; &#x00437;&#x00430;&#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00435;&#x00441;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x00441;&#x00442;&#x0043e;&#x00440;&#x0043e;&#x0043d;&#x00430;&#x0043c;&#x00438;.</p></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>The introduction of genomic technology has led to a biomedical revolution. Whole-genome sequencing and genome-wide association studies have become powerful tools to investigate environmental, genetic, social and behavioural determinants of human diseases.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="R2" ref-type="bibr"><sup>2</sup></xref> Many countries have set up biobanks to collect human biological samples and their associated data for genomic research and public health purposes. To maximize the utilization of biobanking resources, regional and transnational biobank networks, such as the BBMRI-ERIC (Biobanking and Biomolecular Resources Research Infrastructure), the International HapMap Project and the International Cancer Genome Consortium, have been established.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref><sup>&#x02013;</sup><xref rid="R5" ref-type="bibr"><sup>5</sup></xref> Although genetics and genomics have contributed to better understanding of causes and mechanisms of human diseases, some researchers are concerned that genetic research conducted to date has mainly focused on the health needs of high-income countries, thus increasing health inequity between people in poor and rich nations.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref><sup>&#x02013;</sup><xref rid="R8" ref-type="bibr"><sup>8</sup></xref> Low- and middle-income countries are benefiting less than high-income countries from the applications of epidemiological and genetic research. It has been suggested that the disadvantage could partly be attributable to the lack of biobanks and large cohort studies in poorer countries.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref> To find indigenous solutions to health improvement, biobanks have recently been set up in several developing countries (e.g. China, Gambia, India and Mexico).<xref rid="R10" ref-type="bibr"><sup>10</sup></xref><sup>&#x02013;</sup><xref rid="R14" ref-type="bibr"><sup>14</sup></xref></p><p>The establishment and proper running of a biobank can be perceived as an overwhelming task, since researchers have to consider a series of ethical, legal and social issues, such as informed consent, benefit sharing, confidentiality, ownership, commercialization and public participation.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref><sup>&#x02013;</sup><xref rid="R18" ref-type="bibr"><sup>18</sup></xref> Building transnational biobank networks is even more difficult, as these require sharing of samples and interoperability of data in a mutually-applicable ethical and legal framework. However, such frameworks differ between countries.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> Compared with the situation in high-income countries, where the ethical, legal and social issues of biobanks have been debated, researchers in low- and middle-countries are less experienced in coping with these issues.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="R20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="R21" ref-type="bibr"><sup>21</sup></xref> The fear of exploitation &#x02013; i.e. unfair distribution of risks and benefits &#x02013; makes many low- to middle-income countries hesitant about foreign researchers accessing and using their human biological samples and associated data.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref><sup>&#x02013;</sup><xref rid="R25" ref-type="bibr"><sup>25</sup></xref> Furthermore, research participants may sometimes not be fully aware of the risks of participation.<xref rid="R22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="R25" ref-type="bibr"><sup>25</sup></xref> Therefore, the proliferation of biobanks in low- and middle- income countries has led to ethical, cross-border and benefit-sharing issues not witnessed in other human research areas, due to local culture, religious beliefs and poor awareness of developed countries&#x02019; concept of ethics.<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> These issues may have a negative impact on international research collaborations. In this paper, we argue that it is important to develop a governance framework at the global level to guarantee equity, fairness and justice in biobank collaboration between developing and developed countries.</p></sec><sec><title>Biobanks in developing countries</title><p>Biobanks currently exist on every continent, including Antarctica, with most located in North America and Europe.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> However, this landscape is changing rapidly.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="R14" ref-type="bibr"><sup>14</sup></xref> Some countries, including China, Gambia, Jordan, Mexico and South Africa, have placed great effort into building their own biobanks and biobanking networks.<xref rid="R10" ref-type="bibr"><sup>10</sup></xref><sup>&#x02013;</sup><xref rid="R14" ref-type="bibr"><sup>14</sup></xref> In <xref ref-type="table" rid="T1">Table&#x000a0;1</xref>, we present the aim of biobanks with publicly available information and how these biobanks are funded. All the selected biobanks have partnered with facilities in high-income countries. The Kadoorie Study of Chronic Disease in China and the Mexico City Prospective Study collaborate with Oxford&#x02019;s Clinical Trial Service Unit and Epidemiological Studies Unit.<xref rid="R28" ref-type="bibr"><sup>28</sup></xref><sup>,</sup><xref rid="R29" ref-type="bibr"><sup>29</sup></xref> The KHCCBIO project in Jordan, that will collect cancer specimens within the country and from its neighbouring countries, collaborates with Trinity College Dublin, Biost&#x000f3;r Ireland and Accelopment AG, Switzerland.<xref rid="R30" ref-type="bibr"><sup>30</sup></xref> The centralized Gambian National DNA Bank was created with help from the <italic>Centre d'Etude du Polymorphisme Humain</italic>, an international genetic research centre located in Paris, France.<xref rid="R31" ref-type="bibr"><sup>31</sup></xref> Human Heredity and Health in Africa (H3Africa) is based on a partnership among the African Society of Human Genetics, the National Institutes of Health in the United States of America and the Wellcome Trust.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="R32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="R33" ref-type="bibr"><sup>33</sup></xref></p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Biobanks in developing countries with publicly available information</title></caption><table frame="hsides" rules="groups"><col width="114" span="1"/><col width="77" span="1"/><col width="156" span="1"/><col width="304" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Name</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Year established</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Funding</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Aim</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mexico City Prospective Study</td><td valign="top" align="center" rowspan="1" colspan="1">1994</td><td valign="top" align="left" rowspan="1" colspan="1">Mexican Ministry of Health, the Wellcome Trust</td><td valign="top" align="left" rowspan="1" colspan="1">A cohort study of 150&#x02009;000 adults older than 34 years to assess the association between risk factors and common causes of death</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Gambian National DNA Bank</td><td valign="top" align="center" rowspan="1" colspan="1">2000</td><td valign="top" align="left" rowspan="1" colspan="1">United Kingdom Medical Research Council, <italic>Centre d&#x02019;Etude du Polymorphisme Humain</italic></td><td valign="top" align="left" rowspan="1" colspan="1">The first national DNA bank in Africa with focuses on genetic analysis of infectious diseases such as malaria, HIV and tuberculosis, in western African populations</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">China Kadoorie Biobank</td><td valign="top" align="center" rowspan="1" colspan="1">2004</td><td valign="top" align="left" rowspan="1" colspan="1">Kadoorie Charitable Foundation, the Wellcome Trust</td><td valign="top" align="left" rowspan="1" colspan="1">To investigate genetic and non-genetic causes of many common chronic diseases in 500&#x02009;000 Chinese people aged 30&#x02013;79 years</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">H3 (Human, Heredity and Health) Africa</td><td valign="top" align="center" rowspan="1" colspan="1">2010</td><td valign="top" align="left" rowspan="1" colspan="1">African Society of Human Genetics, United States&#x02019; National Institutes of Health, the Wellcome Trust</td><td valign="top" align="left" rowspan="1" colspan="1">To increase the genomic knowledge in the African population</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">KHCCBIO</td><td valign="top" align="center" rowspan="1" colspan="1">2011</td><td valign="top" align="left" rowspan="1" colspan="1">European Union</td><td valign="top" align="left" rowspan="1" colspan="1">The first cancer biobank in Jordan, which aims to collect 10&#x02009;000 specimens from cancer patients in Jordan and its neighbouring countries</td></tr></tbody></table><table-wrap-foot><p>DNA: deoxyribonucleic acid; HIV: human immunodeficiency virus; KHCCBIO: King Hussein Cancer Centre Biobank.</p><p>Data sources: Klingstr&#x000f6;m,<xref rid="R10" ref-type="bibr"><sup>10</sup></xref> Lawlor et al.,<xref rid="R11" ref-type="bibr"><sup>11</sup></xref> Rudan et al.,<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> Sgaier et al.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref> and Vaught et al.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref></p></table-wrap-foot></table-wrap><p>The establishment of biobanks is an important step towards establishing national genomics research programmes. However, development of biobanks can face challenges. Maintaining these biobanks and producing effective scientific outcomes based on the biobanking resources are not easy without a proper framework and the capacity to manage biobanks. In addition, some countries &#x02013; such as China and South Africa &#x02013; lack adequate legislative structures and governance frameworks that regulate the use and development of biobanks.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref><sup>,</sup><xref rid="R29" ref-type="bibr"><sup>29</sup></xref></p></sec><sec><title>Cross-border issues</title><p>Facilities in high-income countries conducting human genetic research may see an advantage in examining human samples from populations with rich genetic diversity in low- and-middle income countries. The samples can either be shipped from the biobank in the low- or middle-income country to the research facility or researchers can come and collect the samples from the biobank.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> These cross-border flows of biological samples and data are troublesome for low- and middle-income countries, since many of these countries have poor or absent medical and patents laws and/or regulatory frameworks. The lack of legislative structures makes both countries and their people vulnerable to exploitation.<xref rid="R25" ref-type="bibr"><sup>25</sup></xref></p><p>In December 2000 <italic>The Washington Post</italic> published a six-part series titled <italic>The body hunters</italic> that surveyed research subjects in China, Africa and Latin America. The research subjects claimed they did not receive the expected benefits &#x02013; such as health care services &#x02013; when participating in medical research led by high-income countries.<xref rid="R34" ref-type="bibr"><sup>34</sup></xref> There have also been reports of researchers from high-income countries collecting blood samples from Hagahai people in Papua New Guinea, Havasupai people in Arizona, United States of America, and the Karitiana people in Brazil without securing proper informed consent. The participants reported that they were disappointed not to receive the benefits they expected and felt they deserved, such as financial compensation and medicines.<xref rid="R24" ref-type="bibr"><sup>24</sup></xref></p><p>In India, although the government issued regulations against biopiracy in 2002, this was poorly implemented and biological samples are still shipped abroad for studies without the proper approval from authorities.<xref rid="R35" ref-type="bibr"><sup>35</sup></xref> A systematic review of all human genetic studies using Cameroonian deoxyribonucleic acid (DNA) samples published between 1989 and 2009, found that only 14% of Cameroonian institutions and 28% of Cameroonian authors were associated with any of the identified 50 articles. Moreover, very few studies were on the most common genetic diseases in African populations. Almost all of the Cameroonian DNA samples are stored outside Africa.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref></p><p>In genetic research, benefit-sharing issues are usually central when it comes to possible exploitation cases. In general, benefits can be shared at two levels: (i)&#x000a0;at an individual level; and (ii)&#x000a0;at a community, tribe or national level.<xref rid="R36" ref-type="bibr"><sup>36</sup></xref> Benefits can also be shared directly and indirectly. Direct benefits include access to medical care for the participating research subjects and/or communities. Indirect benefits include research-capacity building, such as publications, fund-raising, research staff training and development of a stronger scientific culture. Data sharing in genomic research and human biobanks comprises one form of benefit sharing, even though there are issues with data sharing &#x02013; such as who owns the data, which third parties can benefit and who decides what can be shared. Researchers may also gain financial benefits, personal recognition and reputation through access to and commercialization of biobanking resources, which could potentially violate the interests of research participants.<xref rid="R37" ref-type="bibr"><sup>37</sup></xref> Unfair benefit-sharing with local participants and communities may constitute exploitation, and contribute to a public distrust of biomedical research. In addition, poor consent procedures and inadequate engagement, both at an individual and community level complicate the relationship between researchers and participants.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="R24" ref-type="bibr"><sup>24</sup></xref></p><p>Benefit-sharing issues in cross-border flows of samples and data have previously been debated. Several studies have discussed and made suggestions for fair benefit-sharing in genetic research collaboration between countries.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="R25" ref-type="bibr"><sup>25</sup></xref><sup>,</sup><xref rid="R29" ref-type="bibr"><sup>29</sup></xref><sup>,</sup><xref rid="R36" ref-type="bibr"><sup>36</sup></xref><sup>,</sup><xref rid="R38" ref-type="bibr"><sup>38</sup></xref><sup>,</sup><xref rid="R39" ref-type="bibr"><sup>39</sup></xref> However, the conceptual and practical problems of benefit-sharing remain unsolved. Some international organizations have developed ethical and legal policies to promote benefit sharing and data access &#x02013; such as the Human Genome Organization Ethics Committee&#x02019;s <italic>Statement on Benefit Sharing</italic> (2000), the United Nations Educational, Scientific and Cultural Organization&#x02019;s (UNESCO&#x02019;s) <italic>International Declaration on Human Genetic Data</italic> (2003) and the Organisation for Economic Co-operation and Development&#x02019;s <italic>Principles and Guidelines for Access to Research Data from Public Funding</italic> (2007). However, these organizations and policies provide inconsistent and incomplete frameworks, and none of them possess supra-national status, authority or enforceability.<xref rid="R37" ref-type="bibr"><sup>37</sup></xref></p></sec><sec><title>Global governance of biobanks</title><p>Low- and middle-income countries have weaker research capacity and governance mechanisms for biobanks than high-income countries.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref><sup>,</sup><xref rid="R40" ref-type="bibr"><sup>40</sup></xref> It is important to develop a feasible and equitable governance framework at the global level to guarantee benefit sharing in biobank collaboration. The potential commercial benefits resulting from access to the data of biobanks underscores the urgent need for such a framework.</p><p>International initiatives &#x02013; such as the Public Population Project in Genomics and Society,<xref rid="R41" ref-type="bibr"><sup>41</sup></xref> the International Society for Biological and Environmental Repositories<xref rid="R42" ref-type="bibr"><sup>42</sup></xref> and the International Agency for Research on Cancer<xref rid="R43" ref-type="bibr"><sup>43</sup></xref> &#x02013; have offered governance structures, best practices and guidelines to promote the internationalization and standardization of biobanks. An international research group has created the ELSI 2.0 initiative to accelerate the translation of ethical, legal and social knowledge into policy and practice. ELSI 2.0 invites people working with biobanks, policy-makers, funders, the public and other stakeholders to be engaged in ethical, legal and social research.<xref rid="R44" ref-type="bibr"><sup>44</sup></xref> In addition, international organizations should harmonize the multiple existing standards, best practices and guidelines, and consolidate these into a single global governance framework for biobank operation and collaboration.</p><p>We propose a provisional global governance framework for biobanks that includes the following six key elements: (i)&#x000a0;respecting participants and donors of biological samples, and protecting their privacy and confidentiality; (ii)&#x000a0;informing participants and donors of potential risks through initial consultations; (iii)&#x000a0;sharing samples, data and benefits in a fair, transparent and equitable manner; (iv)&#x000a0;ensuring quality and interoperability of samples and their associated data; (v)&#x000a0;improving public awareness, trust and participation in biobanks; and (vi)&#x000a0;defining the role of the private sector in the use of knowledge derived from biobank operations.</p><p>As a step towards global governance, the Global Alliance for Genomics and Health was formed in 2013 to convene global stakeholders from more than 210 leading institutions across different sectors. The alliance aims to enable responsible data-sharing for genomic innovation and discovery. The Global Alliance proposes a provisional <italic>Framework for Responsible Sharing of Genomic and Health-Related Data</italic>,<xref rid="R45" ref-type="bibr"><sup>45</sup></xref> which includes all of the six elements we propose. The framework is currently available from <ext-link ext-link-type="uri" xlink:href="http://genomicsandhealth.org/">http://genomicsandhealth.org/</ext-link> and is open for comments, and provides a setting for further discussions among key stakeholders and interested parties. A key question will be the legitimacy and implementation of any proposed framework or guidelines on data-sharing. We call upon the following organizations to jointly develop a comprehensive global framework to ensure that the benefits of biobanks will be shared by all: the World Health Organization, UNESCO, the World Intellectual Property Organization, the World Trade Organization and the World Medical Association.</p></sec></body><back><fn-group><title>Funding:</title><fn fn-type="supported-by"><p>Haidan Chen&#x02019;s research was supported by the Chinese Universities Scientific Fund (2014RC010). Tikki Pang&#x02019;s research was supported by SRSS Grant R-603-000-129-720 from the Lee Kuan Yew School of Public Policy.</p></fn></fn-group><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Rosenberg</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Jewett</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Szpiech</surname>
<given-names>ZA</given-names></string-name>, <string-name><surname>Jankovic</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Boehnke</surname>
<given-names>M</given-names></string-name>. <article-title>Genome-wide association studies in diverse populations.</article-title><source>Nat Rev Genet</source>. <year>2010</year><month>5</month>;<volume>11</volume>(<issue>5</issue>):<fpage>356</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2760</pub-id><pub-id pub-id-type="pmid">20395969</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Singer</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Daar</surname>
<given-names>AS</given-names></string-name>. <article-title>Harnessing genomics and biotechnology to improve global health equity.</article-title><source>Science</source>. <year>2001</year><month>10</month><day>5</day>;<volume>294</volume>(<issue>5540</issue>):<fpage>87</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1126/science.1062633</pub-id><pub-id pub-id-type="pmid">11588248</pub-id></mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Kaye</surname>
<given-names>J</given-names></string-name>. <article-title>From single biobanks to international networks: developing e-governance.</article-title><source>Hum Genet</source>. <year>2011</year><month>9</month>;<volume>130</volume>(<issue>3</issue>):<fpage>377</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-011-1063-0</pub-id><pub-id pub-id-type="pmid">21785980</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Scott</surname>
<given-names>CT</given-names></string-name>, <string-name><surname>Caulfield</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Borgelt</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Illes</surname>
<given-names>J</given-names></string-name>. <article-title>Personal medicine&#x02013;the new banking crisis.</article-title><source>Nat Biotechnol</source>. <year>2012</year><month>2</month>;<volume>30</volume>(<issue>2</issue>):<fpage>141</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2116</pub-id><pub-id pub-id-type="pmid">22318029</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Vaught</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hewitt</surname>
<given-names>R</given-names></string-name>. <article-title>A review of international biobanks and networks: success factors and key benchmarks.</article-title><source>Biopreserv Biobank</source>. <year>2009</year><month>9</month>;<volume>7</volume>(<issue>3</issue>):<fpage>143</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1089/bio.2010.0003</pub-id><pub-id pub-id-type="pmid">24835880</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Bustamante</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Burchard</surname>
<given-names>EG</given-names></string-name>, <string-name><surname>De la Vega</surname>
<given-names>FM</given-names></string-name>. <article-title>Genomics for the world.</article-title><source>Nature</source>. <year>2011</year><month>7</month><day>14</day>;<volume>475</volume>(<issue>7355</issue>):<fpage>163</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/475163a</pub-id><pub-id pub-id-type="pmid">21753830</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Daar</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Thorsteinsd&#x000f3;ttir</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>DK</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Nast</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Singer</surname>
<given-names>PA</given-names></string-name>. <article-title>Top ten biotechnologies for improving health in developing countries.</article-title><source>Nat Genet</source>. <year>2002</year><month>10</month>;<volume>32</volume>(<issue>2</issue>):<fpage>229</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1038/ng1002-229</pub-id><pub-id pub-id-type="pmid">12355081</pub-id></mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Hardy</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>S&#x000e9;guin</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Goodsaid</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Jimenez-Sanchez</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Singer</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Daar</surname>
<given-names>AS</given-names></string-name>. <article-title>The next steps for genomic medicine: challenges and opportunities for the developing world.</article-title><source>Nat Rev Genet</source>. <year>2008</year><month>10</month>;<volume>9</volume><issue>Suppl 1</issue>:<fpage>S23</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2444</pub-id><pub-id pub-id-type="pmid">18802418</pub-id></mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Rudan</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Chopra</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Aulchenko</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Baqui</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Bhutta</surname>
<given-names>ZA</given-names></string-name>, <string-name><surname>Edmond</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal><article-title>The case for launch of an international DNA-based birth cohort study.</article-title><source>J Glob Health</source>. <year>2011</year><month>6</month>;<volume>1</volume>(<issue>1</issue>):<fpage>39</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">23198101</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Klingstr&#x000f6;m</surname>
<given-names>T</given-names></string-name>. <article-title>Biobanking in emerging countries.</article-title><source>Biopreserv Biobank</source>. <year>2013</year><month>12</month>;<volume>11</volume>(<issue>6</issue>):<fpage>329</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1089/bio.2013.1161</pub-id><pub-id pub-id-type="pmid">24835361</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Lawlor</surname>
<given-names>RT</given-names></string-name>, <string-name><surname>Sluss</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Langer</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sughayer</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Igbe</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Siddiqui</surname>
<given-names>K</given-names></string-name>, <etal>et al.</etal><article-title>European, Middle Eastern, and African Society for biopreservation and biobanking (ESBB). 2012 Conference Session on Biobanking in Emerging Countries.</article-title><source>Biopreserv Biobank</source>. <year>2013</year><month>6</month>;<volume>11</volume>(<issue>3</issue>):<fpage>176</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1089/bio.2013.0017</pub-id><pub-id pub-id-type="pmid">24850095</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Rudan</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Maru&#x00161;i&#x00107;</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Campbell</surname>
<given-names>H</given-names></string-name>. <article-title>Developing biobanks in developing countries.</article-title><source>J Glob Health</source>. <year>2011</year><month>6</month>;<volume>1</volume>(<issue>1</issue>):<fpage>2</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">23198094</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Sgaier</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Jha</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Mony</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Kurpad</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lakshmi</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Kumar</surname>
<given-names>R</given-names></string-name>, <etal>et al.</etal><article-title>Public health. Biobanks in developing countries: needs and feasibility.</article-title><source>Science</source>. <year>2007</year><month>11</month><day>16</day>;<volume>318</volume>(<issue>5853</issue>):<fpage>1074</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.1149157</pub-id><pub-id pub-id-type="pmid">18006727</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Vaught</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bledsoe</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Watson</surname>
<given-names>P</given-names></string-name>. <article-title>Biobanking on multiple continents: will international coordination follow?</article-title><source>Biopreserv Biobank</source>. <year>2014</year><month>2</month>;<volume>12</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1089/bio.2014.1211</pub-id><pub-id pub-id-type="pmid">24620763</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Vaught</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lockhart</surname>
<given-names>NC</given-names></string-name>. <article-title>The evolution of biobanking best practices.</article-title><source>Clin Chim Acta</source>. <year>2012</year><month>10</month><day>9</day>;<volume>413</volume>(<issue>19-20</issue>):<fpage>1569</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2012.04.030</pub-id><pub-id pub-id-type="pmid">22579478</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Hoeyer</surname>
<given-names>K</given-names></string-name>. <article-title>The ethics of research biobanking: a critical review of the literature.</article-title><source>Biotechnol Genet Eng Rev</source>. <year>2008</year>;<volume>25</volume>(<issue>1</issue>):<fpage>429</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.5661/bger-25-429</pub-id><pub-id pub-id-type="pmid">21412365</pub-id></mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Cambon-Thomsen</surname>
<given-names>A</given-names></string-name>. <article-title>The social and ethical issues of post-genomic human biobanks.</article-title><source>Nat Rev Genet</source>. <year>2004</year><month>11</month>;<volume>5</volume>(<issue>11</issue>):<fpage>866</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1038/nrg1473</pub-id><pub-id pub-id-type="pmid">15520796</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Knoppers</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Chadwick</surname>
<given-names>R</given-names></string-name>. <article-title>Human genetic research: emerging trends in ethics.</article-title><source>Nat Rev Genet</source>. <year>2005</year><month>1</month>;<volume>6</volume>(<issue>1</issue>):<fpage>75</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/nrg1505</pub-id><pub-id pub-id-type="pmid">15630423</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Watson</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>Ravid</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Eng</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Litton</surname>
<given-names>J-E</given-names></string-name>, <string-name><surname>Vaught</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Matusan</surname>
<given-names>A</given-names></string-name>. <article-title>What are the main roadblocks to transnational biobank collaboration, and how can we overcome them?</article-title><source>Biopreserv Biobank</source>. <year>2011</year><month>9</month>;<volume>9</volume>(<issue>3</issue>):<fpage>213</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1089/bio.2011.9340</pub-id><pub-id pub-id-type="pmid">24850325</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Abayomi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Christoffels</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Grewal</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Karam</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Rossouw</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Staunton</surname>
<given-names>C</given-names></string-name>, <etal>et al.</etal><article-title>Challenges of biobanking in South Africa to facilitate indigenous research in an environment burdened with human immunodeficiency virus, tuberculosis, and emerging noncommunicable diseases.</article-title><source>Biopreserv Biobank</source>. <year>2013</year><month>12</month>;<volume>11</volume>(<issue>6</issue>):<fpage>347</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1089/bio.2013.0049</pub-id><pub-id pub-id-type="pmid">24835364</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Wonkam</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kenfack</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Muna</surname>
<given-names>WFT</given-names></string-name>, <string-name><surname>Ouwe-Missi-Oukem-Boyer</surname>
<given-names>O</given-names></string-name>. <article-title>Ethics of human genetic studies in sub-saharan Africa: the case of Cameroon through a bibliometric analysis.</article-title><source>Dev World Bioeth</source>. <year>2011</year><month>12</month>;<volume>11</volume>(<issue>3</issue>):<fpage>120</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-8847.2011.00305.x</pub-id><pub-id pub-id-type="pmid">21781234</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="book"><string-name><surname>Sleeboom-Faulkner</surname>
<given-names>M</given-names></string-name>, editor. <source>Human genetic biobanks in Asia: Politics of trust and scientific advancement.</source><publisher-loc>London</publisher-loc>: <publisher-name>Routledge</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Schulz-Baldes</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Vayena</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Biller-Andorno</surname>
<given-names>N</given-names></string-name>. <article-title>Sharing benefits in international health research. Research-capacity building as an example of an indirect collective benefit.</article-title><source>EMBO Rep</source>. <year>2007</year><month>1</month>;<volume>8</volume>(<issue>1</issue>):<fpage>8</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/sj.embor.7400886</pub-id><pub-id pub-id-type="pmid">17203095</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Emerson</surname>
<given-names>CI</given-names></string-name>, <string-name><surname>Singer</surname>
<given-names>PA</given-names></string-name>, <string-name><surname>Upshur</surname>
<given-names>RE</given-names></string-name>. <article-title>Access and use of human tissues from the developing world: ethical challenges and a way forward using a tissue trust.</article-title><source>BMC Med Ethics</source>. <year>2011</year>;<volume>12</volume>(<issue>2</issue>):<fpage>2</fpage>. <pub-id pub-id-type="doi">10.1186/1472-6939-12-2</pub-id><pub-id pub-id-type="pmid">21266076</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Dickenson</surname>
<given-names>D</given-names></string-name>. <article-title>Consent, commodification and benefit-sharing in genetic research.</article-title><source>Dev World Bioeth</source>. <year>2004</year><month>12</month>;<volume>4</volume>(<issue>2</issue>):<fpage>109</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-8731.2004.00087.x</pub-id><pub-id pub-id-type="pmid">15516211</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Morris</surname>
<given-names>K</given-names></string-name>. <article-title>Revising the Declaration of Helsinki.</article-title><source>Lancet</source>. <year>2013</year><month>6</month><day>1</day>;<volume>381</volume>(<issue>9881</issue>):<fpage>1889</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60951-4</pub-id><pub-id pub-id-type="pmid">23734387</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="book"><string-name><surname>Meslin</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Goodman</surname>
<given-names>K</given-names></string-name>. <source>Biobanks and electronic health records: Ethical and policy challenges in the genomic age.</source><publisher-loc>Indianapolis</publisher-loc>: <publisher-name>Center for Applied Cybersecurity Research, Indiana University</publisher-name>; <year>2009</year>.</mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Tapia-Conyer</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Kuri-Morales</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Alegre-D&#x000ed;az</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Whitlock</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Emberson</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Clark</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal><article-title>Cohort profile: The Mexico City prospective study.</article-title><source>Int J Epidemiol</source>. <year>2006</year><month>4</month>;<volume>35</volume>(<issue>2</issue>):<fpage>243</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyl042</pub-id><pub-id pub-id-type="pmid">16556648</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname>
<given-names>H,</given-names></string-name><collab>Governing International Biobank Collaboration</collab>. <article-title>A Case Study of China Kadoorie Biobank.</article-title><source>Sci Technol Soc</source>. <year>2013</year>;<volume>18</volume>(<issue>3</issue>):<fpage>321</fpage>&#x02013;<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1177/0971721813498497</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Barr</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Souan</surname>
<given-names>L</given-names></string-name>, <string-name><surname>MacGabhann</surname>
<given-names>P</given-names></string-name>, <string-name><surname>M&#x000fc;ller</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Al Ashhab</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Jasser</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal><article-title>The establishment of an ISO compliant cancer biobank for Jordan and its neighboring countries through knowledge transfer and training.</article-title><source>Biopreserv Biobank</source>. <year>2014</year><month>2</month>;<volume>12</volume>(<issue>1</issue>):<fpage>3</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1089/bio.2013.0072</pub-id><pub-id pub-id-type="pmid">24620764</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Sirugo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Schim van der Loeff</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sam</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Nyan</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Pinder</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hill</surname>
<given-names>AV</given-names></string-name>, <etal>et al.</etal><article-title>A national DNA bank in The Gambia, West Africa, and genomic research in developing countries.</article-title><source>Nat Genet</source>. <year>2004</year><month>8</month>;<volume>36</volume>(<issue>8</issue>):<fpage>785</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/ng0804-785</pub-id><pub-id pub-id-type="pmid">15284842</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Bruinenberg</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Frey</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Napier</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Summers</surname>
<given-names>A</given-names></string-name>. <article-title>Comparing the hub-and-spoke model practices of the LifeLines Study in the Netherlands and the H3Africa Initiative.</article-title><source>Biopreserv Biobank</source>. <year>2014</year><month>2</month>;<volume>12</volume>(<issue>1</issue>):<fpage>13</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1089/bio.2013.0057</pub-id><pub-id pub-id-type="pmid">24620765</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="web">H3Africa: Human heredity and health in Africa [Internet]. Bethesda: Human Heredity and Health in Africa (H3Africa) Initiative; 2013. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.h3africa.org">http://www.h3africa.org</ext-link> [cited 2014 Aug 10].</mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="web">Stephens J, Nelson D, Flaherty MP. The Body hunters. The Washington Post, 2000 Dec 17. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.washingtonpost.com/wp-dyn/content/article/2008/10/01/AR2008100101373.html?sid=ST2008100101390">http://www.washingtonpost.com/wp-dyn/content/article/2008/10/01/AR2008100101373.html?sid=ST2008100101390</ext-link> [cited 2014 Nov 10].</mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="book"><string-name><surname>Kumar</surname>
<given-names>NK</given-names></string-name>. <chapter-title>India&#x02019;s preparedness in tackling biopiracy and biobanking: still miles to go.</chapter-title> In: <string-name><surname>Sleeboom-Faulkner</surname>
<given-names>M</given-names></string-name>, editor. <source>Human genetic biobanks in Asia: Politics of trust and scientific advancement.</source><publisher-loc>London</publisher-loc>: <publisher-name>Routledge</publisher-name>; <year>2009</year> pp. <fpage>142</fpage>&#x02013;<lpage>50</lpage>.</mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Ndebele</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Musesengwa</surname>
<given-names>R</given-names></string-name>. <article-title>Will developing countries benefit from their participation in genetics research?</article-title><source>Malawi Med J</source>. <year>2008</year><month>6</month>;<volume>20</volume>(<issue>2</issue>):<fpage>67</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4314/mmj.v20i2.10960</pub-id><pub-id pub-id-type="pmid">19537436</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Knoppers</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Abdul-Rahman</surname>
<given-names>MH</given-names></string-name>, <string-name><surname>B&#x000e9;dard</surname>
<given-names>K</given-names></string-name>. <article-title>Genomic databases and international collaboration.</article-title><source>Kings Law J</source>. <year>2007</year>;<volume>18</volume>:<fpage>291</fpage>&#x02013;<lpage>312</lpage>.</mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="journal"><string-name><surname>Sch&#x000fc;klenk</surname>
<given-names>U</given-names></string-name>, <string-name><surname>Kleinsmidt</surname>
<given-names>A</given-names></string-name>. <article-title>North-South benefit sharing arrangements in bioprospecting and genetic research: a critical ethical and legal analysis.</article-title><source>Dev World Bioeth</source>. <year>2006</year><month>12</month>;<volume>6</volume>(<issue>3</issue>):<fpage>122</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">17038004</pub-id></mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><string-name><surname>Simm</surname>
<given-names>K</given-names></string-name>. <article-title>Benefit-sharing: an inquiry regarding the meaning and limits of the concept in human genetic research.</article-title><source>Genomics Soc Policy.</source><year>2005</year>;<volume>1</volume>(<issue>2</issue>):<fpage>29</fpage>&#x02013;<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1186/1746-5354-1-2-29</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><string-name><surname>Wonkam</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Muna</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Ramesar</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rotimi</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Newport</surname>
<given-names>MJ</given-names></string-name>. <article-title>Capacity-building in human genetics for developing countries: initiatives and perspectives in sub-Saharan Africa.</article-title><source>Public Health Genomics</source>. <year>2010</year>;<volume>13</volume>(<issue>7-8</issue>):<fpage>492</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">21135570</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="web">P3G [Internet]. Montreal: Public Population Project in Genomics and Society; 2014. Available from: <ext-link ext-link-type="uri" xlink:href="http://p3g.org/resources/biobank-toolkit">http://p3g.org/resources/biobank-toolkit</ext-link> [cited 2014 Nov 7].</mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="web">ISBER [Internet]. Vancouver: International Society for Biological and Environmental Repositories; 2014. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.isber.org/">http://www.isber.org/</ext-link> [cited 2014 Nov 7].</mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="web">IARC [Internet]. Lyon: International Agency for Research on Cancer; 2014. Available from: <ext-link ext-link-type="uri" xlink:href="http://ibb.iarc.fr/">http://ibb.iarc.fr/</ext-link> [cited 2014 Nov 7].</mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="journal"><string-name><surname>Kaye</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Meslin</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Knoppers</surname>
<given-names>BM</given-names></string-name>, <string-name><surname>Juengst</surname>
<given-names>ET</given-names></string-name>, <string-name><surname>Desch&#x000ea;nes</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Cambon-Thomsen</surname>
<given-names>A</given-names></string-name>, <etal>et al.</etal><article-title>Research priorities. ELSI 2.0 for genomics and society.</article-title><source>Science</source>. <year>2012</year><month>5</month><day>11</day>;<volume>336</volume>(<issue>6082</issue>):<fpage>673</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1126/science.1218015</pub-id><pub-id pub-id-type="pmid">22582247</pub-id></mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="web">Framework for Responsible Sharing of Genomic and Health-Related Data. Toronto: The Global Alliance for Genomics and Health; 2014. Available from: <ext-link ext-link-type="uri" xlink:href="http://genomicsandhealth.org/files/public/Framework%20for%20Responsible%20Sharing%20of%20Genomic%20and%20Health-Related%20Data%20-%20Version%2010%20September%202014.pdf">http://genomicsandhealth.org/files/public/Framework%20for%20Responsible%20Sharing%20of%20Genomic%20and%20Health-Related%20Data%20-%20Version%2010%20September%202014.pdf</ext-link> [cited 2014 Nov 21].</mixed-citation></ref></ref-list></back></article>